World's Best Scientists 2026 revealed!
Charles Catton

Charles Catton

D-Index & Metrics

Medicine

D-Index
91
Citations
27265
World Ranking
11850
National Ranking
476

Charles Catton publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Charles Catton sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 523 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Charles Catton D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Charles Catton sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Charles Catton is affiliated with the University of Toronto in Canada, focusing primarily on medical research with expertise spanning several subfields of study.

Their work is concentrated in the field of Medicine, featuring extensive contributions to:

  • Pulmonary and Respiratory Medicine
  • Radiation
  • Surgery
  • Radiology, Nuclear Medicine and Imaging
  • Oncology

The main research topics covered by Charles Catton include:

  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Advanced Radiotherapy Techniques
  • Sarcoma Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Vascular Tumors and Angiosarcomas
  • Urinary and Genital Oncology Studies

Frequent publication venues where their research has appeared consist of:

  • Radiotherapy and Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Clinical Oncology
  • Annals of Surgical Oncology
  • Brachytherapy

Recent significant papers by Charles Catton include:

  • "Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial," 2020, The Lancet
  • "Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis," 2023, The Lancet Oncology
  • "Clinical integration of machine learning for curative-intent radiation treatment of patients with prostate cancer," 2021, Nature Medicine
  • "Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis," 2021, European Urology
  • "A biochemical definition of cure after brachytherapy for prostate cancer," 2020, Radiotherapy and Oncology

Charles Catton frequently collaborates with colleagues including:

  • Peter Chung
  • Alejandro Berlín
  • Padraig Warde
  • Srinivas Raman
  • David Shultz

Best Publications

  • Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial

    Brian O'Sullivan;Aileen M Davis;Robert Turcotte;Robert Turcotte;Robert Bell;Robert Bell

  • Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy

    Andrew J. Stephenson;Peter T. Scardino;Michael W. Kattan;Thomas M. Pisansky

  • Cardiac tumours: diagnosis and management

    Jagdish Butany;Jagdish Butany;Vidhya Nair;Ather Naseemuddin;Girish M Nair;Girish M Nair

  • Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma

    Aileen M. Davis;Aileen M. Davis;Brian O'Sullivan;Robert Turcotte;Robert Bell;Robert Bell

  • Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer

    Charles N. Catton;Himu Lukka;Chu-Shu Gu;Jarad M. Martin

  • Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C

    B.J Cummings;T.J Keane;B O'Sullivan;C.S Wong

  • Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database.

    Jacqueline A. Crosby;Charles N. Catton;Aileen Davis;Jean Couture;Jean Couture

  • Chordoma: long-term follow-up after radical photon irradiation

    Charles Catton;Brian O'Sullivan;Robert Bell;Normand Laperriere

  • Development of RTOG Consensus Guidelines for the Definition of the Clinical Target Volume for Postoperative Conformal Radiation Therapy for Prostate Cancer

    Jeff M. Michalski;Colleen Lawton;Issam El Naqa;Mark Ritter

  • Outcome and prognosis in retroperitoneal soft tissue sarcoma

    Charles N. Catton;Brian O'Sullivan;Cyrus A Kotwall;Bernard Cummings

  • Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate.

    Douglas J. Moseley;Elizabeth A. White;Kirsty L. Wiltshire;Tara Rosewall

  • Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence

    C. H. Gerrand;J. S. Wunder;R. A. Kandel;B. O’Sullivan

  • Cancer-related fatigue and associated disability in post-treatment cancer survivors.

    Jennifer M. Jones;Karin Olson;Pamela Catton;Charles N. Catton

  • Function and Health Status Outcomes in a Randomized Trial Comparing Preoperative and Postoperative Radiotherapy in Extremity Soft Tissue Sarcoma

    Aileen M. Davis;B. O'Sullivan;R. S. Bell;R. Turcotte

  • Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial

    Christopher C Parker;Noel W Clarke;Adrian D Cook;Howard G Kynaston

  • Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer

    Michael Milosevic;Padraig Warde;Padraig Warde;Cynthia Ménard;Cynthia Ménard;Peter Chung;Peter Chung

  • Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma

    Julia J. Jones;Charles N. Catton;Charles N. Catton;Brian O’Sullivan;Brian O’Sullivan;Jean Couture;Jean Couture

  • Outcome and prognostic factors in soft tissue sarcoma in the adult

    J. Levay;B. O'sullivan;C. Catton;R. Bell

  • Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma.

    Timothy M. Pawlik;Peter W Pisters;Lynn Mikula;Barry W Feig

  • Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma.

    Brian O'Sullivan;Anthony M. Griffin;Colleen I. Dickie;Michael B. Sharpe

Frequent Co-Authors

Brian O'Sullivan
Brian O'Sullivan Princess Margaret Cancer Centre
Padraig Warde
Padraig Warde Princess Margaret Cancer Centre
Jay S. Wunder
Jay S. Wunder University of Toronto
Mary K. Gospodarowicz
Mary K. Gospodarowicz Princess Margaret Cancer Centre
Michael Milosevic
Michael Milosevic Princess Margaret Cancer Centre
Robert G. Bristow
Robert G. Bristow University of Manchester
Aileen M. Davis
Aileen M. Davis University of Toronto
David A. Jaffray
David A. Jaffray The University of Texas MD Anderson Cancer Center
Bernard Cummings
Bernard Cummings Princess Margaret Cancer Centre
Robert E. Bristow
Robert E. Bristow University of California, Irvine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Looking to broaden your career options in the healthcare field beyond studying medicine? Several flexible online programs make it possible to enter healthcare professions quickly and with fewer barriers.

For those seeking a fast-track route into advanced nursing without prior nursing experience, direct entry msn programs for non-nursing majors online offer a pathway to earn a Master of Science in Nursing in a shorter period. If becoming a Registered Nurse is your goal, finding the easiest rn program can help you get started without overly strict admissions requirements.

Healthcare also offers essential administrative career opportunities. Studying at one of the medical billing and coding financial aid accredited schools can open doors for those interested in medical office operations, often with financial support available.

Prefer a route from Licensed Practical Nurse (LPN) to RN without additional entrance exams? Explore lpn to rn programs without teas test requirements to advance your qualifications. Each path offers unique advantages and entry points into healthcare careers.

Best Scientists Citing Charles Catton

Trending Scientists

Recently Published Articles